June M McKoy

Summary

Affiliation: Northwestern University
Country: USA

Publications

  1. pmc Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) project
    June M McKoy
    The Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Drug Saf 36:335-47. 2013
  2. pmc Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project
    June M McKoy
    Department of Medicine, Northwestern University Feinberg School of Medicine, and Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois 60611, USA
    Drug Saf 32:147-58. 2009
  3. pmc Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project
    Charles L Bennett
    VA Center for Management of Complex Chronic Care at Jesse Brown VA Medical Center, Division of Hematology Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA
    J Am Coll Cardiol 50:1138-43. 2007
  4. pmc Epoetin-associated pure red cell aplasia: past, present, and future considerations
    June M McKoy
    Division of Hematology Oncology and Geriatric Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Transfusion 48:1754-62. 2008
  5. doi request reprint Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
    Charles L Bennett
    VA Chicago Healthcare System, Department of Medicine, Northwestern University Feinberg School of Medicine, and Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois 60611, USA
    JAMA 299:914-24. 2008
  6. ncbi request reprint Reassessments of ESAs for cancer treatment in the US and Europe
    Charles L Bennett
    VA Center for the Management of Complex Chronic Care, VA Chicago Healthcare System, Chicago, Illinois, USA
    Oncology (Williston Park) 24:260-8. 2010
  7. pmc Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project
    Beatrice J Edwards
    Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    J Oncol Pract 9:101-6. 2013
  8. pmc Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project
    Charles L Bennett
    MidWest Center for Health Services Research and Policy Studies, VA Chicago Healthcare System, Chicago, IL, USA
    Blood 106:3343-7. 2005
  9. pmc Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?
    Elizabeth A Richey
    Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, 303 E Chicago Ave, Chicago, IL 60611, USA
    J Clin Oncol 27:4398-405. 2009
  10. ncbi request reprint Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project
    Charles L Bennett
    VA Midwest Center for Health Services and Policy Research, the Jesse Brown VA Medical Center, Chicago, IL, USA
    Br J Haematol 135:642-50. 2006

Detail Information

Publications36

  1. pmc Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) project
    June M McKoy
    The Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Drug Saf 36:335-47. 2013
    ....
  2. pmc Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project
    June M McKoy
    Department of Medicine, Northwestern University Feinberg School of Medicine, and Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois 60611, USA
    Drug Saf 32:147-58. 2009
    ..We describe the incidence of hepatotoxicity with short- versus long-course nevirapine-containing regimens in these groups...
  3. pmc Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project
    Charles L Bennett
    VA Center for Management of Complex Chronic Care at Jesse Brown VA Medical Center, Division of Hematology Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA
    J Am Coll Cardiol 50:1138-43. 2007
    ..We sought to describe clinical and laboratory findings for a large cohort of patients with thienopyridine-associated thrombotic thrombocytopenic purpura (TTP)...
  4. pmc Epoetin-associated pure red cell aplasia: past, present, and future considerations
    June M McKoy
    Division of Hematology Oncology and Geriatric Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Transfusion 48:1754-62. 2008
    ..In 1998, epoetin-associated pure red cell aplasia (PRCA) was first reported and causation was attributed to formulations without human serum albumin (HSA), subcutaneous administration, and uncoated rubber stoppers...
  5. doi request reprint Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
    Charles L Bennett
    VA Chicago Healthcare System, Department of Medicine, Northwestern University Feinberg School of Medicine, and Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois 60611, USA
    JAMA 299:914-24. 2008
    ..Although systematic overviews of trials have identified venous thromboembolism (VTE) risks, none have identified mortality risks with ESAs...
  6. ncbi request reprint Reassessments of ESAs for cancer treatment in the US and Europe
    Charles L Bennett
    VA Center for the Management of Complex Chronic Care, VA Chicago Healthcare System, Chicago, Illinois, USA
    Oncology (Williston Park) 24:260-8. 2010
    ..In contrast to Europe, where ESA use has increased over time, reassessments of ESA-associated safety concerns in the United States have resulted in marked decrements in ESA use among cancer patients...
  7. pmc Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project
    Beatrice J Edwards
    Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    J Oncol Pract 9:101-6. 2013
    ..To determine whether acute kidney injury (AKI) is identified within the US Food and Drug Administration's Adverse Events and Reporting System (FDA AERS) as an adverse event resulting from bisphosphonate (BP) use in cancer therapy...
  8. pmc Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project
    Charles L Bennett
    MidWest Center for Health Services Research and Policy Studies, VA Chicago Healthcare System, Chicago, IL, USA
    Blood 106:3343-7. 2005
    ..Reinitiation of epoetin therapy among individuals could be considered if antierythropoietin antibodies are undetectable...
  9. pmc Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?
    Elizabeth A Richey
    Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, 303 E Chicago Ave, Chicago, IL 60611, USA
    J Clin Oncol 27:4398-405. 2009
    ....
  10. ncbi request reprint Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project
    Charles L Bennett
    VA Midwest Center for Health Services and Policy Research, the Jesse Brown VA Medical Center, Chicago, IL, USA
    Br J Haematol 135:642-50. 2006
    ..While a causal relationship with haematological malignancies cannot be demonstrated, long-term follow-up among healthy individuals who receive haematopoietic growth factors is needed...
  11. pmc Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening
    Veena Shankaran
    Veterans Affairs VA Chicago Healthcare System and VA Center for Management of Complex and Chronic Care, Chicago, IL, USA
    J Clin Oncol 27:5370-5. 2009
    ..The objective of this secondary analysis is to assess the cost effectiveness of this intervention...
  12. ncbi request reprint Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project
    June M McKoy
    Division of Geriatric Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, 303 E Chicago, Chicago, IL 60611, USA
    Leuk Res 31:599-604. 2007
    ....
  13. pmc Navigating veterans with an abnormal prostate cancer screening test: a quasi-experimental study
    Melissa A Simon
    Robert H, Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA
    BMC Health Serv Res 13:314. 2013
    ..This study evaluates the impact of a patient navigation intervention on timeliness of diagnostic resolution and treatment initiation among veterans with an abnormal prostate cancer screen...
  14. pmc Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project
    Beatrice J Edwards
    Bone Health and Osteoporosis Center, Feinberg School of Medicine, Northwestern University, 676 North Saint Clair, Suite 1350, Chicago, IL 60611, USA
    J Bone Joint Surg Am 95:297-307. 2013
    ..S. FDA (Food and Drug Administration) Adverse Event Reporting System (FAERS) (1996 to 2011), published case reports, and international safety efforts...
  15. ncbi request reprint Adverse effects of drugs used to treat hematologic malignancies: surveillance efforts from the research on adverse drug events and reports project
    Charles L Bennett
    Veterans Affairs Center of Complex Chronic Care, Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois, USA
    Semin Thromb Hemost 33:365-72. 2007
    ..This article reviews the features of the safety program maintained by the U.S. Food and Drug Administration and the RADAR program...
  16. ncbi request reprint Does reimbursement affect physicians' decision making? Examples from the use of recombinant erythropoietin
    June M McKoy
    Division of Geriatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA
    Cancer Treat Res 140:235-51. 2008
  17. pmc Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer
    Beatrice J Edwards
    Bone Health and Osteoporosis Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
    Clin Cancer Res 17:560-8. 2011
    ..Aromatase inhibitors (AIs) have been recently associated with hip fractures. We present a case series of breast cancer survivors and a systematic review of bone health care in breast cancer...
  18. ncbi request reprint Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers
    Charles L Bennett
    Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Arch Intern Med 167:1041-9. 2007
    ..We compare safety efforts for evaluating serious ADRs conducted by the FDA and pharmaceutical manufacturers vs the RADAR project...
  19. ncbi request reprint Systematic review of piperacillin-induced neutropenia
    Marc H Scheetz
    Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL 60611, USA
    Drug Saf 30:295-306. 2007
    ..Report of neutropenia associated with piperacillin usage prior to 15 days of therapy is a novel finding that requires further evaluation. Current reporting methods poorly characterise patient groups at risk...
  20. doi request reprint Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw
    Beatrice J Edwards
    Divisions of Hematology Oncology and Geriatric Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL USA
    Lancet Oncol 9:1166-72. 2008
    ..Better coordination of safety-related pharmacovigilance initiatives is now needed...
  21. pmc Comparison of the sensitivity of a pre-MRI questionnaire and point of care eGFR testing for detection of impaired renal function
    Philip Chang
    Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Acad Radiol 19:1181-5. 2012
    ..This study was done to evaluate the effectiveness of a pre-MR screening questionnaire about kidney disease and to assess POC eGFR detection of additional patients at risk for nephrogenic systemic fibrosis...
  22. doi request reprint Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report
    Beatrice Nardone
    Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N Saint Clair St, Ste 1600, Chicago, IL, 60611, USA
    Pediatr Radiol 44:173-80. 2014
    ..Nephrogenic systemic fibrosis is a fibrosing disorder associated with exposure to gadolinium-based contrast agents in people with severely compromised renal function...
  23. ncbi request reprint Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans
    Michael S Wolf
    Institute for Healthcare Studies, Department of Medicine, Northwestern University, Illinois, USA
    J Clin Oncol 23:8877-83. 2005
    ..The objective of this secondary analysis was to assess the cost effectiveness of the colorectal cancer screening promotion intervention...
  24. ncbi request reprint Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugs
    June M McKoy
    Jesse Brown Veterans Affairs Medical Center Lakeside Community Based Outpatient Clinic, IL, USA
    J Clin Oncol 23:8894-905. 2005
    ..This is expected to greatly impact the practice of outpatient oncology nationwide...
  25. pmc Design of a prostate cancer patient navigation intervention for a Veterans Affairs hospital
    Narissa J Nonzee
    Robert H, Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA
    BMC Health Serv Res 12:340. 2012
    ....
  26. pmc Effects of cancer comorbidity on disease management: making the case for diabetes education (a report from the SOAR program)
    Lauren Irizarry
    Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
    Popul Health Manag 16:53-7. 2013
    ..When diabetes coexists with cancer, management of diabetes often lags, making diabetes education an imperative...
  27. ncbi request reprint The Research on Adverse Drug Events and Reports (RADAR) project
    Charles L Bennett
    Jesse Brown VA Medical Center Mid West Center for Health Services and Policy Research, Chicago, Ill 60611, USA
    JAMA 293:2131-40. 2005
    ....
  28. pmc Amiodarone-associated optic neuropathy: a critical review
    Rod S Passman
    Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Am J Med 125:447-53. 2012
    ..Legal blindness (<20/200) was noted in at least one eye in 20% of cases. Close ophthalmologic surveillance of patients during the tenure of amiodarone administration is warranted...
  29. ncbi request reprint Cost considerations in the management of cancer in the older patient
    June M McKoy
    Division of Geriatrics, Robert H Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Division of Hematology Oncology, Chicago, Illinois 60611, USA
    Oncology (Williston Park) 21:851-7; discussion 858, 860, 862 passim. 2007
    ..Additional research about cancer costs may also lead to reforms in cancer care reimbursement, and therefore provide access to affordable health care for older patients...
  30. ncbi request reprint Pure red-cell aplasia and epoetin therapy
    Charles L Bennett
    MidWest Center for Health Services Research and Policy Studies, Jesse Brown Veterans Affairs Medical Center, Chicago, IL 60611, USA
    N Engl J Med 351:1403-8. 2004
    ....
  31. ncbi request reprint Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening
    Veena Shankaran
    MPP, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, 303 E Chicago Ave, Olson Pavilion Suite 8250, Chicago, IL 60611, USA
    J Clin Oncol 25:5248-53. 2007
    ..The objective of this secondary analysis is to assess the cost-effectiveness of this intervention...
  32. ncbi request reprint Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited
    Elizabeth A Calhoun
    Department of Health Policy and Administration, University of Illinois at Chicago, Chicago, IL 60612, USA
    Pharmacoeconomics 23:767-75. 2005
    ..Future cost-effectiveness studies of medications such as pegfilgrastim should attempt to capture the societal perspective by incorporating productivity-related costs and using base-case rates of FN reported in the literature...
  33. ncbi request reprint Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration
    Anaadriana Zakarija
    VA Chicago Healthcare System, VA Midwest Center for Health Services and Policy Research, Division of Hematology Oncology, Department of Medicine, Northwestern University Medical Center, Chicago, Ill, USA
    Stroke 35:533-7. 2004
    ....
  34. ncbi request reprint Opportunities for disease state management in prostate cancer
    A Simon Pickard
    Department of Pharmacy Practice, Center for Pharmacoeconomic Research College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    Dis Manag 8:235-44. 2005
    ....
  35. ncbi request reprint Assessing cognitive function and capacity in older adults with cancer
    June M McKoy
    From aRobert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois bNorthwestern University Feinberg School of Medicine, Chicago, Illinois cCity of Hope National Medical Center, Duarte, California dSidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland eCorporate Compliance Department, Jazz Pharmaceuticals, Palo Alto, California fUniversity of Utah School of Medicine, Salt Lake City, Utah and gSalt Lake City VA Geriatric Research Education and Clinical Center, Salt Lake City, Utah
    J Natl Compr Canc Netw 12:138-44. 2014
    ....
  36. pmc Older patients' perceptions of medication importance and worth: an exploratory pilot study
    Denys T Lau
    Buehler Center on Aging, Health and Society, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA
    Drugs Aging 25:1061-75. 2008
    ..Cost-related medication non-adherence may be influenced by patients' perceived importance of their medications...